Loading...

Economic Impact of Tissue Testing and Treatments of Metastatic NSCLC in the Era of Personalized Medicine

A paradigm-shift in the management of non-small cell lung cancer (NSCLC) has resulted in many new therapies becoming available for patients with advanced disease. Stratification of treatment by histologic and molecular subtype is recommended to obtain the greatest clinical benefit for patients while...

Full description

Saved in:
Bibliographic Details
Main Authors: Graham, Donna M., Leighl, Natasha B.
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2014
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4170132/
https://ncbi.nlm.nih.gov/pubmed/25295228
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2014.00258
Tags: Add Tag
No Tags, Be the first to tag this record!